Associated Papers
Efficacy of EGFR-Tyrosine Kinase Inhibitors for advanced non-small cell lung cancer patients harboring rare EGFR mutations of exon 18 E709X.
Hao Y et al.
Medical Oncology (northwood, London, England), 2022
Select a paper to view details